BioArctic AB (publ)
SSE:BIOA-B.ST
227.8 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||
Net Income
| 229.249 | -17.442 | -139.723 | -85.012 | 112.538 | 488.794 | 19.294 | 74.631 | 4.844 |
Depreciation & Amortization
| 18.428 | 14.184 | 13.045 | 10.92 | 9.199 | 2.059 | 1.993 | 1.556 | 1.536 |
Deferred Income Tax
| -39.839 | 0 | -1.821 | -12.32 | -90.375 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 16.137 | 2.76 | 1.568 | 1.319 | 0.383 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 13.154 | 24.914 | -5.06 | 26.558 | 403.786 | 50.256 | -2.846 | 621.102 | 0.288 |
Accounts Receivables
| -11.979 | -2.414 | -5.122 | 23.086 | 433.139 | 3.911 | -13.164 | -3.525 | -0.643 |
Inventory
| -25.132 | -27.328 | -0.062 | -3.472 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 25.133 | 27.328 | 0.062 | 3.472 | -29.352 | 46.345 | 0 | 0 | 0 |
Other Working Capital
| 25.132 | 27.328 | 0.062 | 3.472 | -0.001 | 46.345 | 10.318 | 624.627 | 0.931 |
Other Non Cash Items
| 72.565 | -56.054 | -8.466 | -33.806 | -108.366 | -741.165 | -153.768 | -22.158 | -23.102 |
Operating Cash Flow
| 309.694 | -31.638 | -140.457 | -92.341 | 327.165 | -200.056 | -135.327 | 675.131 | -16.434 |
Investing Activities: | |||||||||
Investments In Property Plant And Equipment
| -7.443 | -12.746 | -4.386 | -12.473 | -3.262 | -4.255 | -3.448 | -2.967 | -2.291 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0.635 | -0.005 | -0.011 |
Purchases Of Investments
| -500.042 | -0.018 | -0.027 | -0.051 | -0.011 | 0 | 0 | -0.005 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 1.175 | 0 | 0 | 0 |
Other Investing Activites
| -500.042 | 0.001 | 0.001 | -0.051 | -0.011 | 1.175 | 0.635 | 0 | 0.02 |
Investing Cash Flow
| -507.485 | -12.763 | -4.412 | -12.524 | -3.273 | -3.08 | -2.813 | -2.972 | -2.282 |
Financing Activities: | |||||||||
Debt Repayment
| -0.917 | -8.793 | -7.389 | -6.598 | -6.416 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 14.981 | 5.985 | 0 | 0 | 0 | 0 | 560.218 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | -132.09 | 0 | 0 | -105.1 | 0 |
Other Financing Activities
| -0.001 | -2.808 | -7.389 | -6.598 | -6.416 | 0 | 560.218 | 0 | 0.005 |
Financing Cash Flow
| 14.064 | -2.808 | -7.389 | -6.598 | -138.506 | 0 | 560.218 | -105.1 | 0.005 |
Other Information: | |||||||||
Effect Of Forex Changes On Cash
| -10.093 | 4.19 | 0.723 | -1.367 | 10.077 | 10.076 | -4.241 | 11.64 | -0.266 |
Net Change In Cash
| -193.819 | -43.019 | -151.535 | -112.83 | 195.463 | -193.06 | 417.837 | 578.699 | -18.977 |
Cash At End Of Period
| 611.567 | 805.386 | 848.405 | 999.94 | 1,112.77 | 917.307 | 1,110.367 | 692.53 | 113.831 |